StockNews.com began coverage on shares of NantHealth (NASDAQ:NH – Free Report) in a report released on Tuesday. The brokerage issued a hold rating on the stock.
NantHealth Stock Performance
NASDAQ:NH opened at $0.34 on Tuesday. The company has a market capitalization of $2.63 million, a PE ratio of -0.04 and a beta of 1.82. The company has a 50 day simple moving average of $0.39 and a two-hundred day simple moving average of $0.39. NantHealth has a fifty-two week low of $1.24 and a fifty-two week high of $9.75.
Hedge Funds Weigh In On NantHealth
A number of institutional investors and hedge funds have recently modified their holdings of NH. Atria Wealth Solutions Inc. lifted its holdings in shares of NantHealth by 117.7% in the 2nd quarter. Atria Wealth Solutions Inc. now owns 491,942 shares of the company’s stock worth $205,000 after purchasing an additional 265,949 shares in the last quarter. Millennium Management LLC bought a new position in shares of NantHealth in the 2nd quarter worth $110,000. Goldman Sachs Group Inc. bought a new position in shares of NantHealth in the 2nd quarter worth $36,000. Finally, Susquehanna International Group LLP bought a new position in shares of NantHealth in the 1st quarter worth $25,000. 4.50% of the stock is currently owned by institutional investors.
About NantHealth
NantHealth, Inc engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management.
Featured Articles
- Five stocks we like better than NantHealth
- Using the MarketBeat Dividend Tax Calculator
- Silicon Motion Proves That AI in Motion Stays in Motion
- Bank Stocks – Best Bank Stocks to Invest In
- Undervalued UnitedHealth Group Won’t Be For Long
- Insider Buying Explained: What Investors Need to Know
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.